Thursday, July 20, 2023
Onkos Surgical, a renowned pioneer in musculoskeletal oncology solutions and complex orthopedic procedures, has recently announced the launch of the JTS Extendible Prosthesis. This innovative growing implant is specifically designed to cater to pediatric patients suffering from bone cancer. Simultaneously, the company has unveiled its state-of-the-art manufacturing and research and development (R&D) innovation center at its headquarters in Parsippany, NJ. These developments aim to strengthen the integration and expansion of this groundbreaking technology.
The JTS Extendible Prosthesis represents a revolutionary solution, backed by significant clinical evidence, to meet the unique needs of pediatric patients with bone cancer. Utilizing magnetic technology, the implant expands non-invasively to accommodate the natural growth curve of the patients, preserving limb length equality for young individuals experiencing bone loss due to cancer. This addition to Onkos Surgical's portfolio enhances their ability to provide advanced solutions for pediatric patients.
Patrick Treacy, Founder, and CEO of Onkos Surgical expressed, "This marks a transformative period for our company, built on the foundation of serving surgeons handling complex orthopedic procedures and the patients under their care. Pediatric sarcoma patients, eligible for the JTS growing prosthesis, often undergo intricate treatment cycles that require precision designs within specific timelines. Our investment in manufacturing innovation and design expertise will significantly impact the future for these surgeons, patients, and families, and we take immense pride in catering to their needs."
He further added, "This milestone reflects an exciting evolution for Onkos as we accelerate investments to cater to the pediatric musculoskeletal oncology field and expand our Precision Orthopedics portfolio. The newly unveiled manufacturing facility and innovation center will foster a more agile production environment and provide a world-class experience for our customers. Every aspect of the facility's design is geared toward enhancing speed, capacity, and ownership of the supply chain, thereby optimizing our ability to deliver personalized devices."
With the introduction of the JTS Extendible Prosthesis and the establishment of the state-of-the-art manufacturing and R&D innovation center, Onkos Surgical demonstrates its commitment to advancing medical solutions and addressing the unique needs of pediatric patients with bone cancer. These advancements hold the promise of transforming the landscape of musculoskeletal oncology and improving the lives of young patients and their families.